Pharmaceuticals market research reports by DelveInsight

• Uveal Neoplasms - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Uveal Neoplasms - Pipeline Insight, 2024 Uveal Neoplasms Overview ""Uveal Neoplasms Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Uveal Neoplasms market. A detailed picture of the Uveal Neoplasm ... Read More

• 5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2024 “5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and gro ... Read More

• 5-HT4 Antagonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  5-HT4 Antagonist - Pipeline Insight, 2024 “5-HT4 Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT4 Antagonist development. The report provides detailed coverage of the ... Read More

• Urolithiasis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Urolithiasis - Pipeline Insight, 2024 Urolithiasis Overview ""Urolithiasis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Urolithiasis market. A detailed picture of the Urolithiasis pipeline land ... Read More

• Uterine Fibroids & Endometriosis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Uterine Fibroids & Endometriosis - Pipeline Insight, 2024 Uterine Fibroids & Endometriosis Overview ""Uterine Fibroids & Endometriosis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Uterine Fibro ... Read More

• Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2024 DelveInsight’s, “Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in Relapsing-Remitting Multiple Sclerosis pipeline landscape. It covers ... Read More

• Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2024 Hypoactive Sexual Desire Disorder (HSDD) Overview ""Hypoactive Sexual Desire Disorder (HSDD) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects ... Read More

• Selectin Inhibitor - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Selectin Inhibitor - Pipeline Insight, 2024 “Selectin Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Selectin Inhibitor development. The report provides detailed coverage o ... Read More

• Acute Ocular Pain And Inflammation - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Ocular Pain And Inflammation - Pipeline Insight, 2024 Acute Ocular Pain And Inflammation Overview ""Acute Ocular Pain And Inflammation Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute O ... Read More

• Serotonin Transporter Inhibitor - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Serotonin Transporter Inhibitor - Pipeline Insight, 2024 “Serotonin Transporter Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Serotonin Transporter Inhibitor development. ... Read More

• Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2024 “Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Serotonin Reuptake Inhibitor (SRI) deve ... Read More

• Skin Neoplasms - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Skin Neoplasms - Pipeline Insight, 2024 Skin Neoplasms Overview ""Skin Neoplasms Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Skin Neoplasms market. A detailed picture of the Skin Neoplasms pip ... Read More

• CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Multiple Myeloma pipeline landscape. It cover ... Read More

• Severe Hypoglycemia - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Severe Hypoglycemia - Pipeline Insight, 2024 Severe Hypoglycemia Overview ""Severe Hypoglycemia Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Severe Hypoglycemia market. A detailed picture of th ... Read More

• Retinitis Pigmentosa- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Retinitis Pigmentosa- Pipeline Insight, 2024 DelveInsight’s, “Retinitis Pigmentosa- Pipeline Insight, 2024” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Retinitis Pigmentosa pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

• Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024 DelveInsight’s, “Ventilator Associated Pneumonia - Pipeline Insight, 2024,” report provides comprehensive insights about 13+ companies and 13+ pipeline drugs in Ventilator Associated Pneumonia pipeline landscape. It covers the pipeline d ... Read More

• Focal Segmental Glomerulosclerosis (FSGS) - Epidemiology Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Focal Segmental Glomerulosclerosis (FSGS) - Epidemiology Forecast - 2034 Key Highlights DelveInsight’s analyst projects that among the total diagnosed prevalent cases of FSGS in 7MM approximately 202 thousand with 36% of cases were from the US. According to the analysis conducted by DelveInsight’s, ... Read More

• Malaria - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Malaria - Pipeline Insight, 2024 DelveInsight’s, Malaria - Pipeline Insight, 2024,” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Malaria pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More

• Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024 DelveInsight’s, “Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Post-traumatic Stress Disorder (PTSD) pipeline landscape. It covers th ... Read More

• Staphylococcus Aureus Infection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Staphylococcus Aureus Infection - Pipeline Insight, 2024 Staphylococcus Aureus Infection Overview ""Staphylococcus Aureus Infection Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Staphylococcus A ... Read More

• Anorexia Nervosa - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anorexia Nervosa - Pipeline Insight, 2024 DelveInsight’s, “Anorexia Nervosa - Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anorexia Nervosa pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stag ... Read More

• Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2024 DelveInsight’s, “Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2024” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Interleukin-18 (IL-18) Inhibitor pipeline landscape. It covers the pipeline drug p ... Read More

• Advanced Renal Cell Carcinoma- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Advanced Renal Cell Carcinoma- Pipeline Insight, 2024 DelveInsight’s, “Advanced Renal Cell Carcinoma- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the pipeline drug profiles, i ... Read More

• H3N2 infection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  H3N2 infection - Pipeline Insight, 2024 DelveInsight’s, “H3N2 infection- Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in H3N2 infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage prod ... Read More

• HER2 Negative Breast Cancer- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  HER2 Negative Breast Cancer- Pipeline Insight, 2024 DelveInsight’s, “HER2 Negative Breast Cancer- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2 Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles, includi ... Read More

< prev 45 46 47 48 49 50 next >